>
Organization
Weinheim 216 GmbH & Co. KG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Weinheim 216 GmbH & Co. KG

... effort which is a prime example of the successful integration of the Cytonet and Promethera teams." The acceptance of the NDS completes the validation period ...
... on a global, regional and country level Companies Mentioned: Ocera Therapeutics, Inc.Cytonet GmbH & Co. KGASKA Pharmaceutical Co., Ltd. For more information visit http://www.researchandmarkets.com/research/p8tnr9/hyperammonemia View ...
... a new chapter in comForte's history.' Michael Deissner is joining comForte from Cytonet, a biotech company, where he was one of the Managing Directors for ...
... in Stabilizing Children with Severe Urea Cycle Disorders Awaiting Liver Transplant . Cytonet's Liver Cell Therapy May Be Effective in Stabilizing Children with Severe Urea ...
... Effective in Stabilizing Patients with Urea Cycle Disorders Awaiting Liver Transplant . Cytonet's Liver Cell Therapy May Be Effective in Stabilizing Patients with Urea Cycle ...
... of the Society for Inherited Metabolic Disorders (SIMD) . First Data on Cytonet's Liver Cell Therapy for Urea Cycle Disorders Presented at the Annual Meeting ...
... For Liver Cell Therapy To Treat Urea Cycle Disorders In Children . Cytonet Submits European Approval Application For Liver Cell Therapy To Treat Urea Cycle ...
Subscribe now for full coverage on Weinheim 216 GmbH & Co. KG
Start My Free Trial